TRAW   $1.63  -5.23% Market Closed

Traws Pharma, Inc.
Total Cash 16.89M
totalCashPerShare 16.681
EBITDA -20.63M
Total Debt 0.00
quickRatio 1.706
currentRatio 1.884
Total Revenue 226.00K
debtToEquity
Revenue/Share 0.256
ROA -0.52506
ROE -10.9652405
grossProfits
freeCashflow -11.32M
operatingCashflow -23.18M
earningsGrowth
revenueGrowth 0.0
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -103.228065
profitMargins 0.0
enterpriseValue 99.78M
forwardPE -0.18484443
floatShares 763.75K
sharesOutstanding 3.03M
sharesShort 9.73K
sharesShortPriorMonth 1.72K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.10%
heldPercentInstitutions 0.22%
Short Ratio help_outline 0.52%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -104.242
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -137.05M
trailingEps -148.75%
forwardEps -27.00%
enterpriseToEbitda -4.84
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2024
institutionsCount 25
lastUpdated Nov. 2, 2024, 7:17 a.m.